John Pirro
Visionary leader for Operations
Long Branch,USA
Summary
Visionary leader with a proven track record in steering organizations toward success through strategic planning and effective management. Skilled in building cohesive teams, driving innovation, and enhancing operational efficiency to achieve business objectives. Demonstrated ability to transform challenges into opportunities, resulting in a significant impact on company growth and profitability.
Overview
19
19
years of professional experience
Work History
Chief Scientific Officer
The Hashmi Group
New Delhi, India
01.2022 - Current
- Assessed founders for Angel investor opportunities, contributing to company valuations exceeding $3M USD.
- Evaluated founders to provide The Hashmi Group's investor network with strategic insights on biotech ventures.
- Enhanced investment strategies by integrating risk assessment, regulatory considerations, and industry trend analysis.
Chief Scientific Officer
Sword Bio
Chicago, Illinois
01.2023 - 01.2025
- Integrated statistical AI software to enhance technology capabilities, increasing capacity by 64%.
- Established a CDMO model for lot release, improving overall service delivery.
- Spearheaded the creation of molecular and cell-based oncology services, fostering advancements in diagnostic and therapeutic methodologies.
- Led successful acquisitions, enhancing profitability by 38% and expanding the oncology sector.
Sr. Director of Operations /Sr. Scientific Advisor
KCAS Bioanalysis and Biomarker Services
Kansas City, Kansas
01.2020 - 01.2023
- Developed and executed financial plans, initially boosting profitability by 41% and ensuring a 15% yearly growth rate.
- Resolved a critical immunological oncology issue for ADC therapeutic, securing FDA approval.
- Demonstrated strong leadership by authoring GLP SOPs that align with new FDA guidelines, ensuring integrity and ethical compliance.
Head of SM and LM Operations (COO)
WuXi AppTec
Plainsboro, New Jersey
01.2018 - 01.2020
- Supervised three staff members in managing small and large molecules, improving efficiency by 56%, and profitability by 31%.
- Spearheaded the expansion of cellular laboratory capabilities by implementing advanced qPCR and ddPCR techniques, elevating the company's role in innovative molecular therapeutic research.
- Managed pivotal change management projects for large and small molecules, refining regulatory services and ensuring seamless communication within cross-functional teams.
Large Molecule Advisor/Sr. Scientific Advisor / Consultant
Independent Consultant
Long Branch, New Jersey
01.2014 - 01.2018
- Guided clients in strategic development of monoclonal antibodies and antibody-drug conjugates using innovative technologies.
- Managed client projects and collaborated with business development for international clients, including Korea.
- Directed risk assessment teams to enhance regulatory immunology processes for clients.
- Oversaw regulatory affairs to ensure compliance and facilitate successful project execution.
General Manager
SGS Life Science Services (CDMO)
Fairfield, New Jersey
01.2011 - 01.2013
- Directed site operations with KPIs and increased capacity by 48%.
- Increased sales by 62% and profitability by 22%.
- Oversaw budgeting for $6.4 million site renovation, achieving completion on schedule.
- Successfully passed FDA inspection, demonstrating a commitment to building under GLP and GMP guidance.
COO/Vice President
Synomics Pharma Services
Wareham, Massachusetts
01.2007 - 01.2011
- Spearheaded strategic initiatives in molecular and cell-based services, resulting in 15% annual revenue growth.
- Collaborated with management team to implement effective growth strategies.
COO/Vice President of North America
MDS Pharma Services
Montreal, Canada
01.2006 - 01.2007
- Hired to develop a business process for managing FDA regulatory evaluations from 2003 to 2006.
- Facilitated acceptance of 250 generic reports by the FDA, including Clopidogrel, with my name on each of them.
- Streamlined workflow for re-evaluations of all generic drugs requested by the FDA within 7 months.
Education
BS - Cell Biology
University of Iowa
Iowa City, IowaSkills
- Financial oversight
- Strategic planning
- Organizational efficiency
- Process improvement
- Security management
- Interpersonal skills
- Adaptability
- Decision making
- Financial acumen
- Vision and innovation
- Effective communication
- Integrity and ethics
- Risk management
- Industry expertise
- Research management
- Innovation leadership
- Scientific expertise
- Clinical trial oversight
- Written and verbal communication
- Effective customer communication
- Scientific presentations
- Emotional intelligence
- Delegation skills
- Supply chain management
- Technology integration
- Operational leadership
- Biotech strategy
- Financial analysis
- Client relationship management
- Innovative problem solving
Patents And Publications
- Patent, Rhenium and technetium complexes containing a hypoxia localizing moiety, No. 6,359,120, Linder, Karen, Nunn, Adrian D., Nowotnik, David P., Ramalingam, Kondareddiar, DiRocco, Richard J., Rumsey, William L., Pirro, John P.
- Publication, Artificial Intelligence increases efficiencies and reduces bias for bioanalytical pharmacokinetic studies and anti-drug antibody statistical determinations, John Pirro, Stephanie Pasas-Farmer, Liam Heins, Ruth Ziegler, 08/01/22
- Publication, Recommendations on ELISpot Assay Validation by GCC, Rafiq Islam, Jennifer Vance, Martin Poirier, Jennifer Zimmer, John Pirro, 09/01/22
- Publication, Recommendations on qPCR/ddPCR Assay Validation by GCC, Mark Wissel, Martin Poirier, Christina Satterwhite, John Lin, John Pirro, 10/01/22
Military Experience
US Navy Reserve, SK 2, Groton, Connecticut, CBMU 202
Skill Sets
- Strategic Thinking
- Interpersonal Skills
- Adaptability to changing business
- Decision Making
- Financial Acumen
- Vision and Innovation
- Communication
- Technology Integration
- Integrity and Ethics
- Change Management
- Risk Management
- Always learning
- Problem-solving
- Industry Knowledge
- Emotional Intelligence
- Delegation
- Supply Chain Management
- Financial Investments
Languages
English
Native/ Bilingual
Italian
Elementary
Affiliations
- Saltwater fishing with Family and friends
- Organizing Antic fashion demonstrations with Wife
- Writing Science fiction novels
- Traveling to different parts of the world
- Golf
References
References available upon request.
Work Availability
monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse
Software
Microsoft Word, PowerPoint, Excel, etc
Red Thread AI Statistical software
Work Preference
Work Type
Full TimeWork Location
On-SiteHybridRemoteImportant To Me
Company CultureTeam Building / Company Retreats401k matchStock Options / Equity / Profit SharingPersonal development programsInterests
AI software for data analysis
New Obesity Treatments
New Oncology Treatments
New Immunological Cell treatments
Quote
The hardest thing when you think about focusing. You think focusing is about saying "Yes." No. Focusing is about saying "No." And when you say "No," you piss off people.
Steve Jobs
Timeline
Chief Scientific Officer
Sword Bio
01.2023 - 01.2025
Chief Scientific Officer
The Hashmi Group
01.2022 - Current
Sr. Director of Operations /Sr. Scientific Advisor
KCAS Bioanalysis and Biomarker Services
01.2020 - 01.2023
Head of SM and LM Operations (COO)
WuXi AppTec
01.2018 - 01.2020
Large Molecule Advisor/Sr. Scientific Advisor / Consultant
Independent Consultant
01.2014 - 01.2018
General Manager
SGS Life Science Services (CDMO)
01.2011 - 01.2013
COO/Vice President
Synomics Pharma Services
01.2007 - 01.2011
COO/Vice President of North America
MDS Pharma Services
01.2006 - 01.2007
BS - Cell Biology
University of Iowa